Magee, Jorge A. Bezerra 3:30 PM 15: Elevated effector and target cell transmembrane Tnfα regulates mucosal INCB018424 mw injury in experimental biliary atresia Pranavkumar Shivakumar, James E. Squires, Stephanie Walters, Jorge A. Bezerra 3:45 PM 16: Hepatic Phytosterol Accumulation During Parenteral Nutrition Involves Activation of Macrophages and Cytokine-mediated Suppression of Hepatocellular Sterol Export Systems (ABCG5/8) Padade
Vue, Aimee Anderson, Michael W. Devereaux, Natarajan Balasubramaniyan, Ronald J. Sokol, Karim C. El Kasmi 4:00 PM 17: FXR-mediated Signaling is Impaired in iPS-derived Hepatocytes in PFIC1 (Byler) Disease and is Enhanced by 4-Phenylbutyrate Bing Han, Edgar N. Tafaleng, Frank Chen, Alexandra Dreyzin, Benjamin L. Shneider, Ira J. Fox 4:15 PM 18: Cost-effective analysis of screening for biliary atresia
with the stool color card Douglas Mogul, Mo Zhou, Paul Intihar, Kathleen B. Schwarz, Kevin Frick Parallel 2: Epidemiology of Viral Hepatitis Sunday, November 3 3:00 – 4:30 PM Room 147 MODERATORS: Robert J. Fontana, MD Joseph Ahn, MD, MS 3:00 PM 19: Effects of chronic hepatitis C on pregnancy and perinatal outcomes Po-Hung Chen, Berkeley N. Limketkai, Brian Kim, Tinsay A. Woreta 3:15 http://www.selleckchem.com/products/MK-1775.html PM 20: Development of Hepatitis C Virus infection associated B-Cell Non-Hodgkin Lymphoma is mediated by downregulation of the tumor-suppressive microRNA miR-26b Jan Peveling-Oberhag, Benjamin Rengstl, Frederic C. Chatain, Kyoko Tsukiyama-Kohara, Marco Lucioni, Marco Paulli, Stefan Zeuzem, Martin Leo Hansmann 3:30 PM 21:Hepatitis medchemexpress C Virus Screening and Prevalence among US Veterans in Department
of Veterans Affairs Care in Lisa I. Backus, Pamela S. Belperio, Timothy P. Loomis, Troy A. Shahoumian, Larry A. Mole 3:45 PM 22: Impact of Age on Safety and Treatment Response in Patients with Hepatitis C (HCV) Treated With Boceprevir or Telaprevir Andrew Aronsohn, Tuesdae Stainbrook, Smruti Mohanty, Abdullah Mubarak, James Spivey, Prashant K. Pandya, Thomas Stewart, Michael W. Fried, Ira M. Jacobson 4:00 PM 23: The global burden of liver disease attributable to hepatitis B, hepatitis C, and alcohol: increasing mortality, differing causes Benjamin C. Cowie, Jennifer H. MacLachlan 4:15 PM 24: Hepatitis C Virus (HCV) Antibody Positivity and Predictors among Adult Primary Care Patients: CrossSectional Analysis of a Multi-Site Retrospective Cohort Study Anthony K. Yartel, David B. Rein, Katherine Krauskopf, Omar I. Massoud, Kimberly Ann Brown, Michael B. Fallon, Bryce D. Smith Parallel 3: Fibrosis: Basic Mechanisms and Novel Therapeutics Sunday, November 3 3:00 – 4:30 PM Room 150A MODERATORS: Bryan Copple, PhD Christian Trautwein, MD 3:00 PM 25: Targeting lysyl oxidase like 2 (LOXL2) inhibits collagen cross-linking and accelerates reversal of preestablished liver fibrosis Naoki Ikenaga, Shuhei Yoshida, Susan B.